These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19404004)

  • 21. Recent trends of NFκB decoy oligodeoxynucleotide-based nanotherapeutics in lung diseases.
    Mehta M; Paudel KR; Shukla SD; Allam VSRR; Kannaujiya VK; Panth N; Das A; Parihar VK; Chakraborty A; Ali MK; Jha NK; Xenaki D; Su QP; Wich PR; Adams J; Hansbro PM; Chellappan DK; Oliver BGG; Dua K
    J Control Release; 2021 Sep; 337():629-644. PubMed ID: 34375688
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regression of abdominal aortic aneurysms by simultaneous inhibition of nuclear factor kappaB and ets in a rabbit model.
    Miyake T; Aoki M; Masaki H; Kawasaki T; Oishi M; Kataoka K; Ogihara T; Kaneda Y; Morishita R
    Circ Res; 2007 Nov; 101(11):1175-84. PubMed ID: 17885220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Transcription factors as molecular targets: molecular mechanisms of decoy ODN and their design.
    Tomita N; Ogihara T; Morishita R
    Curr Drug Targets; 2003 Nov; 4(8):603-8. PubMed ID: 14577649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attenuation of murine antigen-induced arthritis by treatment with a decoy oligodeoxynucleotide inhibiting signal transducer and activator of transcription-1 (STAT-1).
    Hückel M; Schurigt U; Wagner AH; Stöckigt R; Petrow PK; Thoss K; Gajda M; Henzgen S; Hecker M; Bräuer R
    Arthritis Res Ther; 2006; 8(1):R17. PubMed ID: 16507120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. cis Element decoy against nuclear factor-kappaB attenuates development of experimental autoimmune myocarditis in rats.
    Yokoseki O; Suzuki J; Kitabayashi H; Watanabe N; Wada Y; Aoki M; Morishita R; Kaneda Y; Ogihara T; Futamatsu H; Kobayashi Y; Isobe M
    Circ Res; 2001 Nov; 89(10):899-906. PubMed ID: 11701617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibitory effects of NFkappaB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model.
    Miyake T; Aoki M; Shiraya S; Tanemoto K; Ogihara T; Kaneda Y; Morishita R
    J Mol Cell Cardiol; 2006 Sep; 41(3):431-40. PubMed ID: 16762361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amelioration of arthritis by intraarticular dominant negative Ikk beta gene therapy using adeno-associated virus type 5.
    Tas SW; Adriaansen J; Hajji N; Bakker AC; Firestein GS; Vervoordeldonk MJ; Tak PP
    Hum Gene Ther; 2006 Aug; 17(8):821-32. PubMed ID: 16942442
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular therapy to inhibit NFkappaB activation by transcription factor decoy oligonucleotides.
    Morishita R; Tomita N; Kaneda Y; Ogihara T
    Curr Opin Pharmacol; 2004 Apr; 4(2):139-46. PubMed ID: 15063357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protection against cartilage and bone destruction by systemic interleukin-4 treatment in established murine type II collagen-induced arthritis.
    Joosten LA; Lubberts E; Helsen MM; Saxne T; Coenen-de Roo CJ; Heinegård D; van den Berg WB
    Arthritis Res; 1999; 1(1):81-91. PubMed ID: 11056663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transfection of NF-κB decoy oligodeoxynucleotide suppresses pulmonary metastasis by murine osteosarcoma.
    Nishimura A; Akeda K; Matsubara T; Kusuzaki K; Matsumine A; Masuda K; Gemba T; Uchida A; Sudo A
    Cancer Gene Ther; 2011 Apr; 18(4):250-9. PubMed ID: 21183950
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decoy oligodeoxynucleotides as novel cardiovascular drugs for cardiovascular disease.
    Morishita R; Aoki M; Kaneda Y
    Ann N Y Acad Sci; 2001 Dec; 947():294-301; discussion 301-2. PubMed ID: 11795277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [NF kappa B decoy for clinical applications].
    Suzuki J; Isobe M
    Nihon Rinsho; 2003 Oct; 61(10):1829-35. PubMed ID: 14577311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parthenolide inhibits pro-inflammatory cytokine production and exhibits protective effects on progression of collagen-induced arthritis in a rat model.
    Liu Q; Zhao J; Tan R; Zhou H; Lin Z; Zheng M; Romas E; Xu J; Sims NA
    Scand J Rheumatol; 2015 May; 44(3):182-91. PubMed ID: 25439190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. STAT3/NF‑κB decoy oligodeoxynucleotides inhibit atherosclerosis through regulation of the STAT/NF‑κB signaling pathway in a mouse model of atherosclerosis.
    An HJ; Gwon MG; Gu H; Bae S; Leem J; Lee JB; Park KK
    Int J Mol Med; 2023 May; 51(5):. PubMed ID: 37026512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NFkappaB decoy oligodeoxynucleotides reduce monocyte infiltration in renal allografts.
    Vos IH; Govers R; Gröne HJ; Kleij L; Schurink M; De Weger RA; Goldschmeding R; Rabelink TJ
    FASEB J; 2000 Apr; 14(5):815-22. PubMed ID: 10744638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptional regulation of NF-kappaB by ring type decoy oligodeoxynucleotide in an animal model of nephropathy.
    Kim KH; Lee ES; Cha SH; Park JH; Park JS; Chang YC; Park KK
    Exp Mol Pathol; 2009 Apr; 86(2):114-20. PubMed ID: 19118545
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypoxia-induced endothelial apoptosis through nuclear factor-kappaB (NF-kappaB)-mediated bcl-2 suppression: in vivo evidence of the importance of NF-kappaB in endothelial cell regulation.
    Matsushita H; Morishita R; Nata T; Aoki M; Nakagami H; Taniyama Y; Yamamoto K; Higaki J; Yasufumi K; Ogihara T
    Circ Res; 2000 May; 86(9):974-81. PubMed ID: 10807870
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice.
    Kawamura I; Morishita R; Tsujimoto S; Manda T; Tomoi M; Tomita N; Goto T; Ogihara T; Kaneda Y
    Gene Ther; 2001 Jun; 8(12):905-12. PubMed ID: 11426330
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advantages of the circular dumbbell decoy in gene therapy and studies of gene regulation.
    Lee IK; Ahn JD; Kim HS; Park JY; Lee KU
    Curr Drug Targets; 2003 Nov; 4(8):619-23. PubMed ID: 14577652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element 'decoy' of nuclear factor-kappaB binding site as a novel molecular strategy.
    Yoshimura S; Morishita R; Hayashi K; Yamamoto K; Nakagami H; Kaneda Y; Sakai N; Ogihara T
    Gene Ther; 2001 Nov; 8(21):1635-42. PubMed ID: 11895002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.